TherapeuticsMD, Inc.

TXMD
$1.97 (- $0.14 - 6.64%)
Last updated: 2026-07-07 03:39 UTC
TXMD Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS88338N1072
CUSIP88338N107
Market Price1.97
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio174.0
EPS0.01
Market Cap$20.1M
Book Value2.37
Price to Book0.734
Beta0.41
52w High2.44
52w Low0.7
Next Earnings DateN/A

TherapeuticsMD, Inc. trades under ticker TXMD on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US88338N1072, CUSIP 88338N107.

About the Company
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Price History